— Know what they know.
Not Investment Advice
Also trades as: HLN.L (LSE) · $vol 125M · HLNCF (OTC) · $vol 0M

HLN NYSE

Haleon plc
1W: -1.0% 1M: +9.8% 3M: -2.0% YTD: +0.7% 1Y: +8.9% 3Y: +27.0%
$10.08
-0.12 (-1.18%)
Pre-Market: $10.00 (-0.08, -0.79%)
Weekly Expected Move ±3.8%
$9 $10 $10 $11 $11
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 72 · $44.3B mcap · 4.42B float · 0.305% daily turnover · Short 49% of daily vol
Credit Risk of going bust: lower than 82% of companies Debt: 19.8% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.16 (down 98%), Haleon plc would be worth roughly what it owes.
Total debt $10.92B against a stock market value of $44.33B.
Distance to default 10.04 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $6.68B (short-term plus half of long-term), stock volatility 23.4%; Altman Z'' 3.98. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$32.6B -5.1% ▼
5Y CAGR: -0.9%
Total Liabilities
$16.1B -10.9% ▼
5Y CAGR: +15.3%
Shareholders Equity
$16.4B +1.4% ▲
5Y CAGR: -8.9%
Cash & Investments
$1.3B -41.3% ▼
5Y CAGR: +31.7%
Total Debt
$8.6B -14.9% ▼
5Y CAGR: +77.6%
Net Debt
$7.3B -8.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$414M$684M$1.0B$2.2B$1.3B
Short-Term Investments$0$0$0$55M$0
Cash & ST Investments$414M$684M$1.0B$2.2B$1.3B
Net Receivables$3.8B$1.5B$1.4B$1.9B$2.1B
Inventory$951M$1.3B$1.4B$1.2B$1.0B
Other Current Assets$5M$434M$907M$223M$78M
Total Current Assets$5.3B$4.1B$4.8B$5.7B$4.5B
Property, Plant & Equip.$1.7B$1.9B$1.9B$1.9B$2.0B
Goodwill & Intangibles$27.2B$28.4B$26.9B$26.2B$25.6B
Long-Term Investments$23M$44M$65M$82M$76M
Other Non-Current Assets$8M$157M$415M$383M$105M
Total Non-Current Assets$29.2B$30.8B$29.2B$28.6B$28.0B
Total Assets$34.5B$34.8B$34.1B$34.3B$32.6B
— Liabilities —
Accounts Payable$1.6B$1.8B$1.9B$2.0B$3.7B
Short-Term Debt$874M$393M$608M$1.4B$835M
Deferred Revenue$11M$23M$0$0$0
Other Current Liabilities$1.4B$1.6B$1.6B$693M$100M
Total Current Liabilities$4.2B$4.4B$4.6B$5.8B$4.9B
Long-Term Debt$0$9.9B$8.7B$8.5B$7.8B
Other Non-Current Liab.$0$384M$424M$311M$218M
Total Non-Current Liabilities$3.7B$14.0B$12.7B$12.3B$11.2B
Total Liabilities$8.0B$18.4B$17.3B$18.1B$16.1B
— Equity —
Common Stock$1M$92M$92M$91M$90M
Retained Earnings$38.0B$26.7B$27.5B$27.3B$27.8B
Accumulated OCI-$11.6B$1.2B-$11.0B$0$0
Total Stockholders Equity$26.4B$16.3B$16.6B$16.2B$16.4B
Total Liabilities & Equity$34.5B$34.8B$34.1B$34.3B$32.6B
— Key Metrics —
Total Debt$991M$10.4B$9.5B$10.1B$8.6B
Net Debt$577M$9.8B$8.4B$7.9B$7.3B
Total Investments$23M$44M$65M$137M$76M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms